Clinical trial
Towards Personalized Dosing of Natalizumab in Multiple Sclerosis
NCT03516526 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Towards Personalized Dosing of Natalizumab in Multiple Sclerosis
- Lead sponsor
- Amsterdam UMC, location VUmc
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 3, 2016
- Completion date
- July 1, 2019
- Enrollment
- 61 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.